de Carvalho Acacia Fernandes Lacerda, Alves Esmeralda Santos, Pitanga Paula Monique Leite, Ribeiro Erlane Marques, Doriqui Maria Juliana Rodovalho, Toralles Maria Betânia Pereira, Topázio Bianca Arcaro, Dos Santos Jéssica Fernandes, de Lima Renata Lúcia Leite Ferreira, Kulikowski Leslie Domenici, Acosta Angelina Xavier
Laboratory of Human Genetics and Mutagenesis, Institute of Biology, Federal University Bahia (UFBA), Salvador, Bahia, Brazil.
Faculty of Medicine Estacio of Juazeiro Norte, Estacio-FMJ, Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil.
J Pediatr Genet. 2022 Nov 14;13(2):90-98. doi: 10.1055/s-0042-1757888. eCollection 2024 Jun.
Intellectual disability (ID) is considered a common neuropsychiatric disorder that affects up to 3% of the population. The etiologic origin of ID may be genetic, environmental, and multifactorial. Chromosomopathies are relatively common among the genetic causes of ID, especially in the most severe cases and those associated with dysmorphic features. Currently, the application of new molecular cytogenetics technologies has increasingly allowed the identification of microdeletions, microduplications, and unbalanced translocations as causes of ID. The objective of this study was to investigate the etiology of ID in patients admitted to a public hospital in Northeastern Brazil. In total, 119 patients with ID who had normal karyotypes and fragile X exams participated in this study. The patients were initially physically examined for microdeletion syndromes and then tested using fluorescence in situ hybridization (FISH), multiplex ligation-dependent probe amplification (MLPA), methylation-sensitive polymerase chain reaction (MS-PCR), and chromosome microarray analysis (CMA), according to clinical suspicion. Patients with no diagnoses after FISH, MLPA, and/or MS-PCR evaluations were subsequently tested by CMA. The rate of etiologic diagnoses of ID in the current study was 28%. FISH diagnosed 25 out of 79 tested (31%), MLPA diagnosed 26 out of 79 tested (32%), MS-PCR diagnosed 7 out of 20 tested (35%), and the single nucleotide polymorphism array diagnosed 6 out of 27 tested (22%). Although the CMA is the most complete and recommended tool for the diagnosis of microdeletions, microduplications, and unbalance translocations in patients with ID, FISH, MLPA, and MS-PCR testing can be used as the first tests for specific syndromes, as long as the patients are first physically screened clinically, especially in the public health networks system in Brazil, where resources are scarce.
智力残疾(ID)被认为是一种常见的神经精神障碍,影响着高达3%的人口。ID的病因可能是遗传、环境和多因素的。染色体病在ID的遗传病因中相对常见,尤其是在最严重的病例以及那些伴有畸形特征的病例中。目前,新的分子细胞遗传学技术的应用越来越多地使得能够识别微缺失、微重复和不平衡易位作为ID的病因。本研究的目的是调查巴西东北部一家公立医院收治的ID患者的病因。共有119例核型正常且脆性X检查正常的ID患者参与了本研究。患者首先接受微缺失综合征的体格检查,然后根据临床怀疑,使用荧光原位杂交(FISH)、多重连接依赖探针扩增(MLPA)、甲基化敏感聚合酶链反应(MS-PCR)和染色体微阵列分析(CMA)进行检测。在FISH、MLPA和/或MS-PCR评估后未确诊的患者随后进行CMA检测。本研究中ID的病因诊断率为28%。FISH在79例检测中诊断出25例(31%),MLPA在79例检测中诊断出26例(32%),MS-PCR在20例检测中诊断出7例(35%),单核苷酸多态性阵列在27例检测中诊断出6例(22%)。尽管CMA是诊断ID患者微缺失、微重复和不平衡易位的最完整且推荐的工具,但只要患者首先进行临床体格筛查,FISH、MLPA和MS-PCR检测可作为特定综合征的首选检测方法,尤其是在巴西资源稀缺的公共卫生网络系统中。